Abiopharma

News list

Ragosa Mark 🔴 sold 12.0K shares of Kiniksa Pharmaceuticals International, plc (KNSA) at $41.89 Transaction Date: Jan 08, 2026 | Filing ID: 000002

Full text

News bot Jan. 9, 2026, 9:40 p.m.
🔍 Ragosa Mark (Executive)

Company: Kiniksa Pharmaceuticals International, plc (KNSA)

Report Date: 2026-01-08
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 12,000
Detailed Transactions and Holdings:
- Sold 12,000 shares of Class A Ordinary Share at $41.89 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,086.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.
- F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.44 and $42.24. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.